Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
4.
Infect Control Hosp Epidemiol ; 43(11): 1686-1688, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-34269167

RESUMO

We surveyed pediatric antimicrobial stewardship program (ASP) site leaders within the Sharing Antimicrobial Reports for Pediatric Stewardship collaborative regarding discharge stewardship practices. Among 67 sites, 13 (19%) reported ASP review of discharge antimicrobial prescriptions. These findings highlight discharge stewardship as a potential opportunity for improvement during the hospital-to-home transition.


Assuntos
Anti-Infecciosos , Gestão de Antimicrobianos , Criança , Humanos , Alta do Paciente , Antibacterianos/uso terapêutico , Prescrições
5.
J Pediatric Infect Dis Soc ; 11(3): 115-118, 2022 Mar 24.
Artigo em Inglês | MEDLINE | ID: mdl-34939654

RESUMO

We conducted a national survey of pediatric infectious diseases (ID) clinicians on outpatient parenteral antibiotic therapy (OPAT) practices and post-discharge ID follow-up. Only 15% of sites required ID consultation for all OPAT. ID division resources for post-discharge care varied. Opportunities exist to increase ID involvement in post-discharge management of serious infections.


Assuntos
Assistência ao Convalescente , Doenças Transmissíveis , Assistência Ambulatorial , Antibacterianos/uso terapêutico , Criança , Doenças Transmissíveis/tratamento farmacológico , Humanos , Pacientes Ambulatoriais , Alta do Paciente
6.
Hosp Pediatr ; 10(1): 20-28, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31871220

RESUMO

OBJECTIVES: Although health systems are increasingly moving toward addressing social determinants of health, social risk screening for hospitalized children is largely unexplored. We sought to determine if inpatient screening was feasible and describe the prevalence of social risk among children and caregivers, with special attention given to children with chronic conditions. METHODS: Caregivers of pediatric patients on the hospitalist service at a children's hospital in the Pacific Northwest completed a social risk survey in 2017. This survey was used to capture items related to caregiver demographics; socioeconomic, psychosocial, and household risks; and adverse childhood experiences (ACEs). Charts were reviewed for child demographics and medical complexity. Results were tabulated as frequency distributions, and analyses compared the association of risk factors with a child's medical complexity by using χ2 tests. RESULTS: A total of 265 out of 304 (87%) caregivers consented to participate. One in 3 families endorsed markers of financial stress (eg, difficulty paying for food, rent, or utilities). Forty percent experienced medical bill or insurance troubles. Caregiver mental health concerns were prevalent, affecting over one-third of all respondents. ACEs were also common, with 38% of children having at least 1 ACE. The presence of any ACE was more likely for children with chronic conditions than those without. CONCLUSIONS: We found that social risk screening in the inpatient setting was feasible; social risk was uniformly common and did not disproportionately affect those with chronic diseases. Knowing the prevalence of social risk may assist in appropriate alignment of interventions tiered by social complexity.


Assuntos
Cuidadores , Criança Hospitalizada , Fatores Sociais , Criança , Proteção da Criança , Família , Humanos , Noroeste dos Estados Unidos , Fatores de Risco
7.
J Pediatric Infect Dis Soc ; 7(2): 136-142, 2018 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-28419343

RESUMO

BACKGROUND: Outpatient parenteral or prolonged oral antibiotic therapy (OPAT) programs reduce inpatient healthcare costs by shifting care to outpatient settings. Care coordination (CC) is a necessary component to successfully transition patients. Our objective was to assess outcomes of provider time spent on nonreimbursable CC activities in a pediatric OPAT program. METHODS: We used a qualitative feasibility pilot design and modified the Care Coordination Measurement Tool. We captured nonreimbursable CC activity and associated outcome(s) among pediatric patients enrolled in OPAT from March 1 to April 30, 2015 (44 work days) at Doernbecher Children's Hospital. We generated summary statistics for this institutional review board-waived QI project. RESULTS: There were 154 nonreimbursable CC encounters conducted by 2 infectious diseases (ID) providers for 29 patients, ages 17 months-15 years, with complex infections. Total estimated time spent on CC was 54 hours, equivalent to at least 6 workdays. Five patients with complex social issues used 37% of total CC time. Of 129 phone events, 38% involved direct contact with families, pharmacies (13%), primary care providers (13%), and home health nursing (11%). Care coordination prevented 10 emergency room (ER) visits and 2 readmissions. Care coordination led to 16 additional, not previously scheduled subspecialist and 13 primary care visits. The OPAT providers billed for 32 clinic visits during the study period. CONCLUSIONS: Nonreimbursable CC work by OPAT providers prevented readmissions and ER visits and helped facilitate appropriate healthcare use. The value of pediatric OPAT involvement in patient care would have been underestimated based on reimbursable ID consultations and clinic visits alone.


Assuntos
Assistência Ambulatorial/organização & administração , Antibacterianos/uso terapêutico , Doenças Transmissíveis/tratamento farmacológico , Hospitais Pediátricos/organização & administração , Cuidado Transicional/organização & administração , Administração Oral , Assistência Ambulatorial/economia , Antibacterianos/administração & dosagem , Redução de Custos , Esquema de Medicação , Estudos de Viabilidade , Humanos , Infusões Parenterais , Oregon , Projetos Piloto , Mecanismo de Reembolso , Cuidado Transicional/economia
8.
South Med J ; 109(1): 53-60, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26741876

RESUMO

OBJECTIVES: Outpatient parenteral antimicrobial therapy (OPAT) is an effective way of treating infections, but complications are common. We identified patient characteristics and OPAT treatment factors associated with increased risk of OPAT-related complications. METHODS: We used a retrospective cohort design that assessed 337 adult patients treated with OPAT for orthopedic and neurosurgical infections between August 1, 2008 and May 30, 2010. Independent variables included demographics, infection characteristics, lead time factors, OPAT treatment factors, and comorbid conditions. Multivariable log-binomial regression was used to estimate the risk of OPAT complications. RESULTS: The mean patient age was 55 years (range 19-87), 86% had an orthopedic infection, and 44% were treated with intravenous vancomycin. OPAT complications were seen in 45% (152/337) of the cohort. Risk ratios for OPAT complications were 1.9 (95% confidence interval 1.4-2.5) in patients having no primary care provider, 1.7 (95% confidence interval 1.3-2.1) for those treated with vancomycin. CONCLUSIONS: Identifying specific patient characteristics and OPAT treatment factors could facilitate OPAT process improvements to reduce the risk of OPAT complications for vulnerable patients.


Assuntos
Anti-Infecciosos/administração & dosagem , Anti-Infecciosos/efeitos adversos , Doenças Ósseas/tratamento farmacológico , Doenças do Sistema Nervoso/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Feminino , Humanos , Injeções Intravenosas , Masculino , Pessoa de Meia-Idade , Ambulatório Hospitalar , Estudos Retrospectivos , Fatores de Risco , Vancomicina/administração & dosagem , Vancomicina/efeitos adversos , Adulto Jovem , beta-Lactamas/efeitos adversos
9.
J Investig Med ; 50(2): 110-5, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-11930948

RESUMO

BACKGROUND: The presence of Type 2 diabetes mellitus (DM) is one of the strongest predictors of cardiovascular disease (CVD) in women. Although the specific mechanisms underlying this increased risk are unknown, one factor that may contribute to CVD in women with Type 2 DM is impaired fibrinolysis. Healthy premenopausal women have a low rate of CVD and excellent fibrinolytic potential. Impairment in fibrinolysis in people with DM has been demonstrated mainly in men, whereas the fibrinolytic potential of women with Type 2 DM has not been characterized well. This pilot study compared fibrinolytic measures in premenopausal women and men with DM with those of healthy age-matched control women and men to help determine whether fibrinolysis is abnormal in women with DM. METHODS: Fibrinolytic measurements included euglobulin clot lysis time (ELT), fibrinogen, plasminogen activator inhibitor 1, and tissue-type plasminogen activator. RESULTS: Poststasis ELT was significantly impaired in the women with DM as compared with the control women. The men with DM had a tendency toward slower poststasis ELT than did the control men, but the differences between the men's groups were not significant. In the women's groups only, we observed a trend toward increased plasminogen activator inhibitor 1 among the women with DM. CONCLUSIONS: Women with DM have a more significant abnormality in poststasis ELT than do men with DM as compared with sex-specific counterparts without DM.


Assuntos
Diabetes Mellitus Tipo 2/metabolismo , Fibrinólise , Adulto , Doenças Cardiovasculares/etiologia , Diabetes Mellitus Tipo 2/complicações , Feminino , Fibrinogênio/metabolismo , Humanos , Masculino , Projetos Piloto , Inibidor 1 de Ativador de Plasminogênio/sangue , Pré-Menopausa , Soroglobulinas/metabolismo , Caracteres Sexuais , Ativador de Plasminogênio Tecidual/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...